Crossmark

Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China

Crossref DOI link: https://doi.org/10.1007/s10096-020-04079-0

Published Online: 2020-10-28

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ding, Yijun

Zhang, Jinjing

Yao, Kaihu

Gao, Wei

Wang, Yajuan https://orcid.org/0000-0002-8830-7255
Funding

Funding for this research was provided by:

Natural Science Foundation of Beijing (7154196)

National Natural Science Foundation of China (81872676)

Beijing Hospitals Authority Youth Programme (QML 20181207)

Natural Science Foundation of Beijing Municipality (7192063)

Beijing Municipal Administration of Hospitals (XTYB201806)
License Information

Text and Data Mining valid from 2020-10-28

Version of Record valid from 2020-10-28
More Information

Article History

Received: 10 August 2020

Accepted: 21 October 2020

First Online: 28 October 2020

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: This study was approved by the Beijing Children’s hospital Ethics Committee (reference number 2017-k-84). The Review Board exempted the requirement for informed consent because this retrospective study only focused on the bacteria and did not affect the patients.

Document is current

Any future updates will be listed below